Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
33.65
+0.87 (2.65%)
At close: Aug 13, 2025, 4:00 PM
31.39
-2.26 (-6.72%)
Pre-market: Aug 14, 2025, 8:57 AM EDT
KNSA Employees
Kiniksa Pharmaceuticals International, had 315 employees as of December 31, 2024. The number of employees increased by 18 or 6.06% compared to the previous year.
Employees
315
Change (1Y)
18
Growth (1Y)
6.06%
Revenue / Employee
$1,680,419
Profits / Employee
$15,206
Market Cap
2.49B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KNSA News
- 15 days ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 20 days ago - Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing Fast - Seeking Alpha
- 2 months ago - Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals: Making Steady Progress - Seeking Alpha
- 3 months ago - Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis - GlobeNewsWire